CY1117082T1 - PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITS - Google Patents
PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITSInfo
- Publication number
- CY1117082T1 CY1117082T1 CY20151100309T CY151100309T CY1117082T1 CY 1117082 T1 CY1117082 T1 CY 1117082T1 CY 20151100309 T CY20151100309 T CY 20151100309T CY 151100309 T CY151100309 T CY 151100309T CY 1117082 T1 CY1117082 T1 CY 1117082T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical composition
- lanthanum compound
- mixture
- powder
- lanthani
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 5
- 150000002604 lanthanum compounds Chemical class 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 3
- 239000000843 powder Substances 0.000 abstract 3
- 238000002156 mixing Methods 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 229910052746 lanthanum Inorganic materials 0.000 abstract 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000005096 rolling process Methods 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Αυτή η εφεύρεση σχετίζεται με μία σύνθεση λανθανίου που μπορεί να μασηθεί που περιλαμβάνει μία φαρμακευτικά αποτελεσματική ποσότητα μιας ένωσης λανθανίου και τουλάχιστον ένα φαρμακευτικά αποδεκτό έκδοχο που μπορεί να μασηθεί. Αυτή η εφεύρεση σχετίζεται με μία φαρμακευτική σύνθεση σε ταμπλέτα ή σε σκόνη που περιλαμβάνει μία φαρμακευτικά αποτελεσματική ποσότητα μιας ένωσης λανθανίου που παράγεται με μία διαδικασία που περιλαμβάνει τα εξής βήματα: a) ανάμιξη σκόνης της ένωσης λανθανίου και ενός τουλάχιστον φαρμακευτικά αποδεκτού εκδόχου μέσα σε ένα αναμικτήρα ώστε να σχηματιστεί ένα μίγμα ή b) ανάμιξη σκόνης της ένωσης λανθανίου και εκδόχων, συμπίεση του συνδυασμού που προκύπτει σε ένα δισκοειδές υλικό ή συμπύκνωση με κύλινδρο σε ένα νηματοειδές υλικό, και άλεση του παρασκευασμένου υλικού σε μίγμα ελεύθερης ροής και c) συμπίεση του μίγματος που προκύπτει σε ταμπλέτα ή γέμισμα του μίγματος που προκύπτει μέσα σε κατάλληλο δοχείο.This invention relates to a chewable lanthanum composition comprising a pharmaceutically effective amount of a lanthanum compound and at least one pharmaceutically acceptable chewable excipient. This invention relates to a tablet or powder pharmaceutical composition comprising a pharmaceutically effective amount of a lanthanum compound produced by a process comprising the following steps: a) mixing the powder of the lanthanum compound and at least one pharmaceutically acceptable excipient into a mixer. to form a mixture or b) mixing powder of the lanthanum compound and excipients, compressing the resulting combination into a disc material or rolling condensation into a filamentary material, and grinding the material prepared in a free flow mixture; and c) compressing the resulting mixture into a tablet or filling the resulting mixture into a suitable container.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49756003A | 2003-08-26 | 2003-08-26 | |
| US51707803A | 2003-11-05 | 2003-11-05 | |
| EP20090172030 EP2133084B1 (en) | 2003-08-26 | 2004-08-26 | Pharmaceutical Formulation Comprising Lanthanum Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117082T1 true CY1117082T1 (en) | 2017-04-05 |
Family
ID=58461552
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100568T CY1115392T1 (en) | 2003-08-26 | 2014-07-28 | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS |
| CY20151100309T CY1117082T1 (en) | 2003-08-26 | 2015-03-30 | PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100568T CY1115392T1 (en) | 2003-08-26 | 2014-07-28 | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS |
Country Status (1)
| Country | Link |
|---|---|
| CY (2) | CY1115392T1 (en) |
-
2014
- 2014-07-28 CY CY20141100568T patent/CY1115392T1/en unknown
-
2015
- 2015-03-30 CY CY20151100309T patent/CY1117082T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1115392T1 (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118211T1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS | |
| WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
| BRPI0418228A (en) | dosage form, and methods of treating pain and incident cancer pain episodes, and preparing a tablet for oral, gingival or sublingual administration of fentanyl | |
| CO5611096A2 (en) | PHARMACEUTICAL DOSAGE FORM FOR MUCOSAL ADMINISTRATION | |
| PA8842701A1 (en) | GRANULATE CONTAINING NICOTINE | |
| BR0206164A (en) | Escitalopram oxalate crystalline particles, method for the production of escitalopram oxalate crystalline particles, and solid unit dosage form | |
| AR033711A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI0409623A (en) | pharmaceutical product, method of preparation thereof and use of substances in the preparation of said pharmaceutical product | |
| NO20063429L (en) | Coarse oral opiate dosage form | |
| AR065970A2 (en) | A SOLID ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND GLIBENCLAMIDE AND USE OF SUCH COMPOSITION | |
| TW200505406A (en) | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base | |
| ATE499939T1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERIN POLYMORPHO A | |
| BRPI0411485A (en) | rasgap-derived peptide to selectively kill cancer cells | |
| DE602004023093D1 (en) | N WITH A DISPENSER IN MICRONIZED FORM | |
| ATE326985T1 (en) | LYOPHILIZED PHARMACEUTICAL COMPOSITION OF PROPOFOL | |
| MXPA06000332A (en) | Novel solid pharmaceutical composition comprising amisulpride. | |
| BRPI0510034A (en) | dosage form for delivery of multiple drug forms | |
| CY1117082T1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITS | |
| BRPI0518789A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| BRPI0518790A2 (en) | pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet | |
| PL378106A1 (en) | Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method | |
| DE60111503D1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN | |
| WO2001083795A3 (en) | Particulate adenovirus, use thereof in vaccination | |
| WO2005037192A3 (en) | Ibuprofen narcotic composition and method for making same |